Paul Song, NKGen Biotech CEO
NK cell therapy-focused biotech eyes SPAC deal
A small, Santa Ana-based biotech created in 2017 is looking to enter a SPAC deal as it lays out plans to begin trials in its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
